<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Darbepoetin; Aranesp preparations" /><meta name="IX" content="Darbepoetin; Aranesp preparations" /><title>Aranesp®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../383/theme.css" /><link type="text/css" rel="stylesheet" href="204/style.css" /><link type="image/x-icon" rel="shortcut icon" href="../../favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP5887-aranesp.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.8/jquery.min.js"></script><script type="text/javascript" src="../../383/scripts.js"></script><style type="text/css">
          .contentsbox { position: fixed; z-index:1001; }
          .contentsbox_wrap { overflow: hidden; width: 20px; height: 130px; position: absolute; left: 0; top: 0; }
        </style><!--[if IE 8]>
          <style type="text/css">
          #p1 {
          float: left;
          padding-bottom: 15em;
          }
          </style>
          <![endif]--><!--[if lte IE 8]>
          <style type="text/css">
          #start-search input {
          height: 28px;
          padding-top: 8px;
          }
          @media screen {
          #pV {
          display: block !important;
          }
          }
          </style>
          <![endif]--><!--[if IE 7]>
          <style type="text/css">
          #start-search input {
          position: absolute !important;
          left: 0;
          top: 0;
          }
          .as-shadow {
          margin-left: -4px !important;
          color: silver;
          }
          </style>
          <![endif]--><!--[if lte IE 7]>
          <style type="text/css">
          .menu {
          height: 1%;
          }
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }

          #account-info ul li a {
          width: 12em;
          }
          #opts ul li span {
          width: 12em;
          }
          div.as-select ul li ul li span {
          width: 40em;
          }
          div.menu ul li ul li {
          float: left !important;
          }
          #pQ fieldset, #qd, #input-box, #pub-list, #start-search, #end-search {
          display: inline;
          float: left;
          height: 100%;
          padding: 0;
          margin: 0;
          position: relative;
          }
          #hM a, #hM a img {
          border: none;
          display: inline-block;
          float: left;
          }
          #qd input {
          float: left;
          display: inline-block !important;
          }
          #start-search input {
          height: 28px;
          padding-top: 8px !important;
          }
          #end-search, #end-search input {
          height: 36px !important;
          }
          #hM, #content, #searchForm, #purple-menu {
          width: expression(document.body.clientWidth > 63 * parseInt(document.body.currentStyle.fontSize) ? '63em': 'auto');
          margin: 0 auto;
          }
          #pQ {
          z-index: 1;
          }
          </style>
          <![endif]--><!--[if lte IE 6]>
          <style type="text/css">
          body {
          height: 100%;
          }
          div.menu ul li a, div.menu ul li span {
          display: inline-block;
          }
          div.menu ul li ul li {
          clear: both;
          }
          div.as-select ul li span {
          height: 20px;
          padding-top: 16px;
          padding-left: 1em;
          padding-bottom: 0;
          padding-left: 1em;
          margin: 4px 0;
          border-right: 1px solid #888;
          background-image: url("images/dropdown_img.png");
          background-repeat: repeat-x;
          overflow-x: hidden;
          }
          div.as-select ul li ul li span {
          font: bold 10px Verdana !important;
          padding: 4px 1em !important;
          color: #2D2D2D;
          background: white;
          text-decoration: none !important;
          white-space: nowrap;
          border: none !important;
          float: left;
          }
          div.menu span.hover {
          background: #8F1F8D;
          color: white;
          }
          </style>
          <![endif]--></head><body><!--[if lte IE 6]>
          <script type="text/javascript">
          jQuery(document).ready(function($) {
          $('a.mclogo').html('<img src="images/mc_logo.gif" class="logo" />');
          });
          </script>
          <![endif]--><?highlighter off?><div id="hC"><div id="vH"><div id="pU"><a class="mclogo" href="http://www.medicinescomplete.com/about/"><img class="logo" src="../../images/mc_logo.png" alt="MedicinesComplete" /></a><div id="hM"><div id="vM" class="menu"><ul><li><a href="http://www.medicinescomplete.com/mc/index.htm">Home</a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm">Help</a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP5887-aranesp.htm">Feedback</a></li><li id="account-info"><a href="http://www.medicinescomplete.com/mc/account.htm">BNF.org Free Access</a><ul><li><a href="http://www.medicinescomplete.com/mc/account.htm">My Account</a></li><li><a href="http://www.medicinescomplete.com/mc/subscribe.htm">Subscribe</a></li><li><a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li><a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul></li></ul></div><a id="pD" accesskey="s" rel="bookmark" href="PHP5887-aranesp.htm#pB" title="Skip Navigation">Skip Navigation</a></div></div><div id="pA"><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 13 Mar 2013 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="search-in">Publication</label><label for="q">Search for</label><div id="qd"><div id="start-search"><div class="as-select menu" id="pub-list"><ul><li><span>British National Formulary</span><ul></ul></li></ul></div><div id="input-box"><input type="text" id="q" name="q" accesskey="4" /></div></div><div id="end-search"><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div></div></div><div id="pH"><div id="pN"><div id="pT"><!--[if lte IE 7]>
             
            <![endif]--><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF March 2013</a> &gt; <a href="PHP5812-nutrition-and-blood.htm">9 Nutrition and blood</a> &gt; <a href="PHP5813-anaemias-and-some-other-blood-disorders.htm">9.1 Anaemias and some other blood disorders</a> &gt; <a href="PHP5877-drugs-used-in-hypoplastic-haemolytic-and-renal-anaemias.htm">9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias</a> &gt; <a href="PHP5880-erythropoietins.htm">Erythropoietins</a> &gt; <a href="PHP5886-darbepoetin-alfa.htm">DARBEPOETIN ALFA</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP5880-erythropoietins.htm" title="Previous: Erythropoietins">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP5888-epoetin-alfa-beta-theta-and-zeta.htm" title="Next: EPOETIN ALFA, BETA, THETA, and ZETA">Next page</a> ►</div></div></div></div><div id="content"><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a301064.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Darbepoetin Alfa</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Blood Formation, Coagulation, and Thrombosis 20:00 &gt; Hematopoietic Agents 20:16</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/22839-k.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Darbepoetin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: D &gt; Interactions of Darbepoetin</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="PHP5880-erythropoietins.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Erythropoietins</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders &gt; 9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias</p></div></li><li><a href="PHP5886-darbepoetin-alfa.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">DARBEPOETIN ALFA</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders &gt; 9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias &gt; Erythropoietins</p></div></li></ul><ul><li><h3>BNF for Children (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13914-erythropoietins.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Erythropoietins</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders &gt; 9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13918-darbepoetin-alfa.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">DARBEPOETIN ALFA</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders &gt; 9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias &gt; Erythropoietins</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13919-aranesp.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Aranesp®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders &gt; 9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias &gt; Erythropoietins &gt; DARBEPOETIN ALFA</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/20270-f.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Darbepoetin Alfa</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Blood Products Plasma Expanders and Haemostatics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/02824.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Darbepoetin Alfa</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; D &gt; DA</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-D11.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Darbepoetin Alfa</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; D</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E4E3E0R0D1722.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Darbepoetin alfa</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; D</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><?highlighter on?><h1>DARBEPOETIN ALFA</h1><?highlighter off?><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT"> see under Dose below</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="target-text: Epoetin alfa and beta cautions " href="PHP5888-epoetin-alfa-beta-theta-and-zeta.htm#PHP5889">Epoetin</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">see <a title="target-text: Epoetin alfa and beta contra-indications" href="PHP5888-epoetin-alfa-beta-theta-and-zeta.htm#PHP5890">Epoetin</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">manufacturer advises caution</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">no evidence of harm in <em>animal</em> studies—manufacturer advises caution </p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">manufacturer advises avoid—no information available</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see <a title="target-block: Epoetin alfa and beta side-effects" href="PHP5888-epoetin-alfa-beta-theta-and-zeta.htm#PHP5891">Epoetin</a>; also, oedema, injection-site pain; isolated reports of pure red cell aplasia, particularly following subcutaneous administration in patients with chronic renal failure (discontinue therapy)—see also <a title="target-block: Erythropoietin CSM advice" href="PHP5880-erythropoietins.htm#PHP5884">notes above</a></p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Symptomatic anaemia associated with chronic renal failure in patients on dialysis (see also <a title="target-block: Erythropoietins MHRA/CHM advice (target haemoglobin concentration)" href="PHP5880-erythropoietins.htm#PHP5882">MHRA/CHM advice</a>), <span class="cP">adult</span> and <span class="cP">child</span> over 11 years, <span class="cK">by subcutaneous</span><em> or </em><span class="cK">intravenous injection</span>, initially 450 nanograms/kg once weekly, adjusted according to response by approx. 25% at intervals of at least 4 weeks; maintenance dose, given once weekly <em>or</em> once every 2 weeks</p></li> </ul></div><div class="cR"><ul><li><p>Symptomatic anaemia associated with chronic renal failure in patients not on dialysis (see also <a title="target-block: Erythropoietins MHRA/CHM advice (target haemoglobin concentration)" href="PHP5880-erythropoietins.htm#PHP5882">MHRA/CHM advice</a>), <span class="cP">adult</span> and <span class="cP">child</span> over 11 years, <span class="cK">by subcutaneous</span><em> or </em><span class="cK">intravenous injection</span>, initially 450 nanograms/kg once weekly <em>or </em><span class="cK">by subcutaneous injection</span>, initially 750 nanograms/kg once every 2 weeks; adjusted according to response by approx. 25% at intervals of at least 4 weeks; maintenance dose, given <span class="cK">subcutaneously</span> or <span class="cK">intravenously</span> once weekly <em>or</em> <span class="cK">subcutaneously</span> once every 2 weeks <em>or</em> <span class="cK">subcutaneously</span> once every month</p></li>  </ul><div class="cF"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Subcutaneous route preferred in patients not on haemodialysis. Reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose. When changing route give same dose then adjust according to weekly or fortnightly haemoglobin measurements. Adjust doses not more frequently than every 2 weeks during maintenance treatment</p></div></div></div><div class="cR"><ul><li><p>Symptomatic anaemia in adults with non-myeloid malignancies receiving chemotherapy (see also <a title="target-block: Erythropoietins MHRA/CHM advice (target haemoglobin concentration)" href="PHP5880-erythropoietins.htm#PHP5882">MHRA/CHM advice</a>), <span class="cK">by subcutaneous injection</span>, initially 6.75 micrograms/kg once every 3 weeks <em>or</em> 2.25 micrograms/kg once weekly (if response inadequate after 9 weeks further treatment may not be effective); if adequate response obtained, reduce dose by 25–50%</p></li>  </ul><div class="cF"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Reduce dose by approximately 25–50% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and restart at a dose approximately 25% lower than the previous dose. Discontinue approximately 4 weeks after ending chemotherapy</p></div></div></div></div>   <div class="cAK"><h2>NICE Technology Appraisal</h2><p>See <a title="Epoetin alfa, beta and darbepoetin alfa for cancer treatment-induced anaemia (May 2008)" href="PHP5880-erythropoietins.htm#PHP5885">Epoetin alfa, beta and darbepoetin alfa for cancer treatment-induced anaemia (May 2008)</a></p></div></div><div id="pS"><p>Sub-sections</p><div id="PHP5887-aranesp" style="margin: 0 0 0 20px;"><h1 class="title">Aranesp® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10036">Amgen</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Injection</strong>, prefilled syringe, darbepoetin alfa, 25 micrograms/mL, net price 0.4 mL (10 micrograms) = £14.68; 40 micrograms/mL, 0.375 mL (15 micrograms) = £22.03, 0.5 mL (20 micrograms) = £29.37; 100 micrograms/mL, 0.3 mL (30 micrograms) = £44.05, 0.4 mL (40 micrograms) = £58.73, 0.5 mL (50 micrograms) = £73.41; 200 micrograms/mL, 0.3 mL (60 micrograms) = £88.09, 0.4 mL (80 micrograms) = £117.45, 0.5 mL (100 micrograms) = £146.81, 0.65 mL (130 micrograms) = £190.86; 500 micrograms/mL, 0.3 mL (150 micrograms) = £220.22, 0.6 mL (300 micrograms) = £440.43, 1 mL (500 micrograms) = £734.05</p></div><div class="cU"><p><strong>Injection</strong>  (<em>Aranesp®SureClick</em>), prefilled disposable injection device, darbepoetin alfa, 40 micrograms/mL, net price 0.5 mL (20 micrograms) = £29.36; 100 micrograms/mL, 0.4 mL (40 micrograms) = £58.72; 200 micrograms/mL, 0.3 mL (60 micrograms) = £88.09, 0.4 mL (80 micrograms) = £117.45, 0.5 mL (100 micrograms) = £146.81; 500 micrograms/mL, 0.3 mL (150 micrograms) = £220.22, 0.6 mL (300 micrograms) = £440.43, 1 mL (500 micrograms) = £734.05</p></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP5880-erythropoietins.htm">Previous: Erythropoietins</a> | <a class="top" href="PHP5887-aranesp.htm#">Top</a> | <a accesskey="]" href="PHP5888-epoetin-alfa-beta-theta-and-zeta.htm">Next: EPOETIN ALFA, BETA, THETA, and ZETA</a> ►</div></div></div></div><div id="pF"><div id="p2"><div id="pL"><div class="p4"><h2>Keep in touch</h2><ul><li><a href="http://www.pharmpress.com/?utm_source=medicinescomplete&amp;utm_medium=footer&amp;utm_campaign=medicinescomplete-referral">Pharmaceutical Press</a></li><li><a href="http://www.rpharms.com/">Royal Pharmaceutical Society</a></li><li><a href="http://www.pharmpress.com/mc-alerts.asp?utm_source=medicinescomplete&amp;utm_medium=footer&amp;utm_campaign=medicinescomplete-referral">Sign up for our eNewsletter</a></li><li><a href="http://twitter.com/#!/PharmPress/" class="p5"><img src="../../images/twitter.png" alt="Twitter logo" />Follow us on Twitter
              </a></li><li><a href="http://www.facebook.com/pages/Pharmaceutical-Press/296104187066918" class="p5"><img src="../../images/facebook.png" alt="Facebook logo" />Find us on Facebook
              </a></li></ul></div><div class="p4"><h2>Help and Support</h2><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a></li><li><a href="http://www.medicinescomplete.com/about/contact.htm">Contact Us</a></li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a></li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a></li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div><div class="p4"><h2>Provided for</h2><div id="cL"><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2013.  All rights reserved.</a></p><p><a href="http://www.medicinescomplete.com/mc/copyright.htm">MedicinesComplete © The Pharmaceutical Press 2013</a></p></div></div></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>